Abstract
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Patel A, Patel H, Patel A. Thrombotic thrombocytopenic purpura: the masquerader. South Med J 2009;102:504–509.PatelA]]PatelH]]PatelAThrombotic thrombocytopenic purpura: the masquerader.South Med J2009102504-5092. Moschowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. An undescribed disease. Arch Intern Med 1925;36:89.MoschowitzEAn acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. An undescribed disease.Arch Intern Med192536893. Bukowski RM, King JW, Hewlitt JS. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 1977;50:413–417.BukowskiRM]]KingJW]]HewlittJSPlasmapheresis in the treatment of thrombotic thrombocytopenic purpura.Blood197750413-4174. Moake JL, Rudy CK, Troll JH, et al. Unusually large plasma factor VIII:von Willibrand factor multimers in chronic, relapsing thrombocytopenic purpura. N Engl J Med 1982;307:1432–1435.MoakeJL]]RudyCK]]TrollJH&etal;Unusually large plasma factor VIII:von Willibrand factor multimers in chronic, relapsing thrombocytopenic purpura.N Engl J Med19823071432-14355. Tsai HM, Lian EC. Antibodies to von Willibrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585–1594.TsaiHM]]LianECAntibodies to von Willibrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.N Engl J Med19983391585-15946. Sadler JE. Von Willibrand factor, ADAM13, and thrombotic thrombocytopenic purpura. Blood 2008;112:11–18.SadlerJEVon Willibrand factor, ADAM13, and thrombotic thrombocytopenic purpura.Blood200811211-187. Scully M, Cohen H, Cavenagh J, et al. Remission in acute refractory and relapsing thromobotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. Br J Haematol 2007;136:451–461.ScullyM]]CohenH]]CavenaghJ&etal;Remission in acute refractory and relapsing thromobotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.Br J Haematol2007136451-461
